Table 2 Comparison of adverse events between the two groups
|  | Aspirin (n = 40) | Cilostazol (n = 40) | P |
|---|---|---|---|
Serious adverse events | 5 | 2 | 0.235 |
 Acute cholecystitis | 0 | 1 | NC |
 Ischemic stroke recurrence | 0 | 1 | NC |
 Bell’s palsy | 1 | 0 | NC |
 Intracerebral hemorrhage | 1 | 0 | NC |
 Thrombocytopenia | 1 | 0 | NC |
 Femur fracture | 1 | 0 | NC |
 Infectious enterocolitis | 1 | 0 | NC |
Adverse events | 25 | 35 | 0.010 |
 Headache | 3 | 14 | 0.003 |
 Anxiety/Palpitation | 3 | 9 | NC |
 Dizziness | 2 | 4 | NC |
 Heartburn /Dyspepsia | 4 | 1 | NC |
 Diarrhea | 1 | 1 | NC |
 Hand tremor | 2 | 1 | NC |
 Itching/skin rash | 3 | 2 | NC |
 Dysuria | 1 | 0 | NC |
 Depression | 1 | 0 | NC |
 Acute rhinitis | 1 | 1 | NC |
 Food allergy | 1 | 0 | NC |
 Hyperglycemia/Hypoglycemia | 0 | 2 | NC |
 Muscle pain | 1 | 0 | NC |
 Liver enzyme elevation | 1 | 0 | NC |
 Tinnitus | 1 | 0 | NC |